A real-world study to assess the economic burden and clinical outcome in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece

被引：0
|
作者：
Karachalios, G. [1 ]
Gourgioti, R. [1 ]
Alexopoulou, A. [1 ]
Kourlaba, G. [2 ]
机构：
[1] Genesis Pharma SA, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Intens Care A, Athens, Greece
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P278
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [41] Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dimethyl fumarate: a real-world study
    Ernst, Frank R.
    Barr, Peri
    Elmor, Riad
    Wong, Schiffon L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (12) : 2099 - 2106
  • [42] The Economic Burden Associated with Fatigue in Relapsing-remitting Multiple Sclerosis
    Le, H.
    Ken-Opurum, J.
    Maculaitis, M.
    Sheehan, J. J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 116 - 116
  • [43] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    Neurology and Therapy, 2020, 9 : 85 - 92
  • [44] Dimethyl fumarate withdrawalFulminant rebound of relapsing-remitting multiple sclerosis: case report
    Reactions Weekly, 2018, 1711 (1) : 108 - 108
  • [45] Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
    Boullosa-Lale, Silvia
    Gonzalez-Freire, Lara
    Martinez-Martinez, Luciano
    Crespo-Diz, Carlos
    FARMACIA HOSPITALARIA, 2021, 45 (02) : 73 - 76
  • [46] Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis
    O'Donnell, Martin
    Pavalaghanthan, Hariesh
    Jose, Shinto
    Mitten, Ethna
    Ryan, Aisling
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1000 - 1001
  • [47] Real-World Efficacy and Safety of Oral Cladribine in Korean Patients with Relapsing-Remitting Multiple Sclerosis
    Kim, Su-Hyun
    Kim, Ho Jin
    Kim, Sung Min
    Shin, Ha Young
    Kwon, Young Nam
    Nam, Tai-Seung
    Kim, Byoung Joon
    Min, Ju-Hong
    Kim, Jun Soon
    Su, Park Min
    Kim, Nam-Hee
    Shin, Jin-Hong
    Park, Young Eun
    Lim, Young-Min
    Lee, Eun-Jae
    Kim, Woojun
    Shon, Eun Hee
    Lee, Tae-Kyeong
    Taha, Karim
    Seo, Beom-Jun
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1099
  • [48] TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program
    Labauge, Pierre
    Creange, Alain
    Moreau, Thibault
    Nouvet-Gire, Jocelyne
    Pedespan, Bernard
    Heinzlef, Olivier
    Texier, Nathalie
    Gros, Marilyn
    Marti, Catherine
    Ruiz, Marta
    Martinez, Mikel
    Castelnovo, Giovanni
    NEUROLOGY AND THERAPY, 2025, 14 (01) : 177 - 192
  • [49] CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY
    Rock, M.
    Dort, T.
    Snyder, S.
    Gitlin, M.
    VALUE IN HEALTH, 2019, 22 : S273 - S273
  • [50] Dimethyl fumarate decreases serum neurofilament light chain in relapsing-remitting multiple sclerosis patients
    Sainz De La Maza, S.
    Walo Delgado, P. E.
    Villarrubia, N.
    Monreal, E.
    Espino, M.
    Fernandez-Velasco, J. I.
    Masjuan, J.
    Costa-Frossard, L.
    Villar, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 149 - 150
12345